İ. ÇELİK Et Al. , "In silico evaluation of potential inhibitory activity of remdesivir, favipiravir, ribavirin and galidesivir active forms on SARS-CoV-2 RNA polymerase," Molecular Diversity , vol.26, no.1, pp.279-292, 2022
ÇELİK, İ. Et Al. 2022. In silico evaluation of potential inhibitory activity of remdesivir, favipiravir, ribavirin and galidesivir active forms on SARS-CoV-2 RNA polymerase. Molecular Diversity , vol.26, no.1 , 279-292.
ÇELİK, İ., EROL, M., & Duzgun, Z., (2022). In silico evaluation of potential inhibitory activity of remdesivir, favipiravir, ribavirin and galidesivir active forms on SARS-CoV-2 RNA polymerase. Molecular Diversity , vol.26, no.1, 279-292.
ÇELİK, İSMAİL, MERYEM EROL, And Zekeriya Duzgun. "In silico evaluation of potential inhibitory activity of remdesivir, favipiravir, ribavirin and galidesivir active forms on SARS-CoV-2 RNA polymerase," Molecular Diversity , vol.26, no.1, 279-292, 2022
ÇELİK, İSMAİL Et Al. "In silico evaluation of potential inhibitory activity of remdesivir, favipiravir, ribavirin and galidesivir active forms on SARS-CoV-2 RNA polymerase." Molecular Diversity , vol.26, no.1, pp.279-292, 2022
ÇELİK, İ. EROL, M. And Duzgun, Z. (2022) . "In silico evaluation of potential inhibitory activity of remdesivir, favipiravir, ribavirin and galidesivir active forms on SARS-CoV-2 RNA polymerase." Molecular Diversity , vol.26, no.1, pp.279-292.
@article{article, author={İSMAİL ÇELİK Et Al. }, title={In silico evaluation of potential inhibitory activity of remdesivir, favipiravir, ribavirin and galidesivir active forms on SARS-CoV-2 RNA polymerase}, journal={Molecular Diversity}, year=2022, pages={279-292} }